ConCallIQ
Go Pro
HCG Diversified 15 Jan 2026

Healthcare Global Enterprises Limited — Q3 FY26

HCG delivered a steady Q3 FY26 with revenue of ₹633 crore (+13.4% YoY) and adjusted EBITDA of ₹111 crore (+20% YoY), with margins expanding 100 bps to 17.5%.

bullish high
Compare with...
Revenue ₹633 Cr +13.4%
EBITDA ₹111 Cr +20%
PAT ₹-8 Cr
EBITDA Margin 17.5% +100bps
Duration 48 min
Read Time 1 min read

✓ Verified against BSE filing

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

Andhra Pradesh scheme disruption

A 20-25 day strike in Andhra Pradesh impacted volumes and revenue in Q3, though resolved by quarter end.

medium · management_commentary
R

Gross margin pressure from medical oncology mix shift

Gross profit margin declined to 72% from ~75% due to higher medical oncology and pharmacy costs, though management expects offset via operating leverage.

medium · analyst_question
R

New greenfield hospitals may temporarily drag margins

The North Bangalore and Whitefield greenfield projects will add beds but may initially pressure margins during ramp-up.

medium · analyst_question
R

Rights issue dilution

The announced rights issue may dilute existing shareholders; specifics not yet disclosed.

low · analyst_question